Literature DB >> 10337999

Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer.

S S Wang1, A Virmani, A F Gazdar, J D Minna, G A Evans.   

Abstract

11q23-24 chromosome is a region containing frequent allelic loss (loss of heterozygosity; LOH) in human cancers. To examine cancer-related allelic loss in the region between D11S940 and APOC3, we used 17 polymorphic markers and allotyped 28 lung cancer-derived cell lines and their corresponding matched lymphoblastoid cell lines. LOH was found in 71.4% (20/28) of the lung cancer cell lines and was localized to two distinct minimal regions of loss. One region is bracketed by markers D11S1647 and NCAM2 and contains the gene encoding the beta isoform of the A subunit of the human protein phosphatase 2A (PPP2R1B). Recently, mutations in this gene were described in lung and colon cancers, suggesting that PPP2R1B functions as a tumor-suppressor gene. A second minimal region of loss was defined between markers D11S1792 and D11S1885, a region estimated to be less than I Mb. Thus, chromosome 11 likely harbors two sites of suppressor oncogene activity in lung cancer, one defined by the PPP2R1B gene and the second located telomeric to PPP2R1B. This study facilitates the identification and cloning of a second critical tumor-suppressor gene involved in lung cancer, and possibly a variety of other cancers, on human chromosome band 11q23.

Entities:  

Mesh:

Year:  1999        PMID: 10337999

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

2.  A common breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation.

Authors:  L Edelmann; E Spiteri; N McCain; R Goldberg; R K Pandita; S Duong; J Fox; D Blumenthal; S R Lalani; L G Shaffer; B E Morrow
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

3.  Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.

Authors:  Dipanjana Mazumder Indra; Sraboni Mitra; Anup Roy; Ranajit Kumar Mondal; Partha Sarathi Basu; Susanta Roychoudhury; Runu Chakravarty; Chinmay Kumar Panda
Journal:  Hum Genet       Date:  2011-06-05       Impact factor: 4.132

4.  Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.

Authors:  S Hemmer; V M Wasenius; C Haglund; Y Zhu; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.

Authors:  Y Takagi; M Futamura; K Yamaguchi; S Aoki; T Takahashi; S Saji
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

6.  Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26.

Authors:  Ziad J Sahab; Michael D Hall; Lihua Zhang; Amrita K Cheema; Stephen W Byers
Journal:  J Cancer       Date:  2010-06-02       Impact factor: 4.207

7.  The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.

Authors:  Eric S Martin; Rossano Cesari; Francesca Pentimalli; Kristine Yoder; Richard Fishel; Andrew L Himelstein; S Eric Martin; Andrew K Godwin; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

8.  Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study.

Authors:  Susanna Petzmann; Reinhard Ullmann; Iris Halbwedl; Helmut H Popper
Journal:  Virchows Arch       Date:  2004-07-03       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.